tradingkey.logo
Markets
News
Analysis
Tools
Learn
Stock Score
English
繁体中文
ไทย
Tiếng việt
简体中文
Español
Português
Deutsch
한국어
日本語
tradingkey.logo

Bicara Therapeutics Inc

BCAX

11.060USD

+0.090+0.82%
Close 09/18, 16:00（ET）Quotes delayed by 15 min
603.39MMarket Cap
LossP/E TTM

Bicara Therapeutics Inc

11.060

+0.090+0.82%
OverviewCompanyFinancialsAnalysis
Statements
Income Statement
Balance Sheet
Cash Flow Statement

Overview

Company

Financials

Analysis

Statements

Income Statement

Balance Sheet

Cash Flow Statement

Quarterly
Quarterly+Annual
Quarterly
Annual
YOY
Hide blank rows
FY2025Q2
FY2025Q1
FY2024Q4
FY2024Q3
FY2024Q1
FY2023Q3
Operating expenses
--32.02M
171.81%41.79M
--26.64M
116.45%20.63M
--15.37M
--9.53M
R&D expenses
--24.80M
185.35%34.33M
--19.88M
128.62%15.86M
--12.03M
--6.94M
Depreciation, depletion, and amortization
--19.00K
46.15%19.00K
--15.00K
650.00%15.00K
--13.00K
--2.00K
Operating profit
---32.02M
-171.81%-41.79M
---26.64M
-116.45%-20.63M
---15.37M
---9.53M
Net non-operating interest income (expenses)
Non-operating interest income
--4.68M
74.89%5.01M
--5.87M
24107.69%3.15M
--2.87M
--13.00K
Special income (expenses)
----
----
--0.00
100.00%0.00
----
---13.33M
Income before tax
---27.34M
-194.03%-36.77M
---20.77M
23.48%-17.48M
---12.51M
---22.84M
Income tax
--52.00K
7100.00%72.00K
--186.00K
--0.00
--1.00K
--0.00
Income after tax
---27.39M
-194.58%-36.85M
---20.96M
23.48%-17.48M
---12.51M
---22.84M
Net income from continuous operations
---27.39M
-194.58%-36.85M
---20.96M
23.48%-17.48M
---12.51M
---22.84M
Net income attributable to controlling interests
---27.39M
-194.58%-36.85M
---20.96M
23.48%-17.48M
---12.51M
---22.84M
Net income attributable to common shareholders
---27.39M
-194.58%-36.85M
---20.96M
23.48%-17.48M
---12.51M
---22.84M
Basic earnings per share
---0.50
96.43%-0.68
---3.19
27.21%-0.32
---18.94
---0.44
Diluted earnings per share
---0.50
96.43%-0.68
---3.19
27.21%-0.32
---18.94
---0.44
Dividend per share
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
Currency unit
USD
USD
USD
USD
USD
USD
Audit opinions
--
--
--
--
--
--
KeyAI